526 related articles for article (PubMed ID: 34356638)
21. Phase separation of the mammalian prion protein: Physiological and pathological perspectives.
do Amaral MJ; Freire MHO; Almeida MS; Pinheiro AS; Cordeiro Y
J Neurochem; 2023 Jul; 166(1):58-75. PubMed ID: 35149997
[TBL] [Abstract][Full Text] [Related]
22. Protein misfolding and amyloid nucleation through liquid-liquid phase separation.
Mukherjee S; Poudyal M; Dave K; Kadu P; Maji SK
Chem Soc Rev; 2024 May; 53(10):4976-5013. PubMed ID: 38597222
[TBL] [Abstract][Full Text] [Related]
23. Modulation of Amyloid States by Molecular Chaperones.
Wentink A; Nussbaum-Krammer C; Bukau B
Cold Spring Harb Perspect Biol; 2019 Jul; 11(7):. PubMed ID: 30755450
[TBL] [Abstract][Full Text] [Related]
24. Metamorphism in TDP-43 prion-like domain determines chaperone recognition.
Carrasco J; Antón R; Valbuena A; Pantoja-Uceda D; Mukhi M; Hervás R; Laurents DV; Gasset M; Oroz J
Nat Commun; 2023 Jan; 14(1):466. PubMed ID: 36709343
[TBL] [Abstract][Full Text] [Related]
25. Prion-Like Characteristics of Polyglutamine-Containing Proteins.
Pearce MMP; Kopito RR
Cold Spring Harb Perspect Med; 2018 Feb; 8(2):. PubMed ID: 28096245
[TBL] [Abstract][Full Text] [Related]
26. Amyloid Properties of Asparagine and Glutamine in Prion-like Proteins.
Zhang Y; Man VH; Roland C; Sagui C
ACS Chem Neurosci; 2016 May; 7(5):576-87. PubMed ID: 26911543
[TBL] [Abstract][Full Text] [Related]
27. Understanding and exploiting interactions between cellular proteostasis pathways and infectious prion proteins for therapeutic benefit.
Yakubu UM; Catumbela CSG; Morales R; Morano KA
Open Biol; 2020 Nov; 10(11):200282. PubMed ID: 33234071
[TBL] [Abstract][Full Text] [Related]
28. Impact of Amyloid Polymorphism on Prion-Chaperone Interactions in Yeast.
Killian AN; Miller SC; Hines JK
Viruses; 2019 Apr; 11(4):. PubMed ID: 30995727
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation sites are evolutionary checkpoints against liquid-solid transition in protein condensates.
Ranganathan S; Dasmeh P; Furniss S; Shakhnovich E
Proc Natl Acad Sci U S A; 2023 May; 120(20):e2215828120. PubMed ID: 37155880
[TBL] [Abstract][Full Text] [Related]
30. [The Prion-like Mechanism in Neurodegenerative Diseases-Current Studies and Future Prospects].
Tarutani A; Hisanaga SI; Hasegawa M
Brain Nerve; 2016 Oct; 68(10):1197-1204. PubMed ID: 27703107
[TBL] [Abstract][Full Text] [Related]
31. Prion-like proteins and their computational identification in proteomes.
Batlle C; Iglesias V; Navarro S; Ventura S
Expert Rev Proteomics; 2017 Apr; 14(4):335-350. PubMed ID: 28271922
[TBL] [Abstract][Full Text] [Related]
32. Composition-based prediction and rational manipulation of prion-like domain recruitment to stress granules.
Boncella AE; Shattuck JE; Cascarina SM; Paul KR; Baer MH; Fomicheva A; Lamb AK; Ross ED
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5826-5835. PubMed ID: 32127480
[TBL] [Abstract][Full Text] [Related]
33. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
Ritchie DL; Barria MA
Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
[TBL] [Abstract][Full Text] [Related]
34. Liquid-liquid phase transitions and amyloid aggregation in proteins related to cancer and neurodegenerative diseases.
de Oliveira GAP; Cordeiro Y; Silva JL; Vieira TCRG
Adv Protein Chem Struct Biol; 2019; 118():289-331. PubMed ID: 31928729
[TBL] [Abstract][Full Text] [Related]
35. The Effect of Octapeptide Repeats on Prion Folding and Misfolding.
Yu KH; Huang MY; Lee YR; Lin YK; Chen HR; Lee CI
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670336
[TBL] [Abstract][Full Text] [Related]
36. Regulation by Different Types of Chaperones of Amyloid Transformation of Proteins Involved in the Development of Neurodegenerative Diseases.
Muronetz VI; Kudryavtseva SS; Leisi EV; Kurochkina LP; Barinova KV; Schmalhausen EV
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269889
[TBL] [Abstract][Full Text] [Related]
37. Protein-solvent interfaces in human Y145Stop prion protein amyloid fibrils probed by paramagnetic solid-state NMR spectroscopy.
Aucoin D; Xia Y; Theint T; Nadaud PS; Surewicz K; Surewicz WK; Jaroniec CP
J Struct Biol; 2019 Apr; 206(1):36-42. PubMed ID: 29679649
[TBL] [Abstract][Full Text] [Related]
38. From Prions to Stress Granules: Defining the Compositional Features of Prion-Like Domains That Promote Different Types of Assemblies.
Fomicheva A; Ross ED
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513942
[TBL] [Abstract][Full Text] [Related]
39. Getting to the core of prion superstructural variability.
Torrent J; Lange R; Igel-Egalon A; Béringue V; Rezaei H
Prion; 2016; 10(1):1-8. PubMed ID: 26636374
[TBL] [Abstract][Full Text] [Related]
40. Structural Mechanism of Barriers to Interspecies Seeding Transmissibility of Full-Length Prion Protein Amyloid.
Ma T; Deng J; Ma S; Zhao W; Chang Z; Yu K; Yang J
Chembiochem; 2019 Nov; 20(21):2757-2766. PubMed ID: 31161647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
